Drug intelligence / Profile preview

Oxysept

Development stage
Unknown
Lead developer
Allergan
Modality
Recombinant Proteins and Enzymes, Small Molecules
01

Overview

Oxysept is a hydrogen peroxide-based contact lens disinfecting system primarily used for the cleaning and disinfection of soft (hydrogel and silicone hydrogel) contact lenses. The system typically utilizes a 3% hydrogen peroxide solution as its active antimicrobial agent. Hydrogen peroxide acts as a potent oxidizing agent, producing free radicals that disrupt the cell membranes and metabolic processes of a wide range of pathogens, including bacteria, fungi, and Acanthamoeba. To ensure safety for ocular use, the peroxide must be neutralized—commonly via a delayed-release catalase tablet—which converts the hydrogen peroxide into water and oxygen over several hours. This process ensures that the lenses are sterile and the solution is isotonic and pH-balanced before lens insertion.

Brand names
OxyseptOxysept 1 StepOxysept1 StepOxysept-1 StepOxysept Disinfecting SystemOxysept Comfort
Other names
Hydrogen peroxide 3% disinfecting solution
02

Targets

Neuraminidase

Beyond the preview

Go deeper on Oxysept.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxysept.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call